Health Canada Approves Portable Human COVID-19 Testing Device - View press release

Test with confidence

Taking sample from fleet vehicle

Test with confidence

Testing for SARS-CoV-2, the virus that causes COVID-19, is a key component of an integrated pathogen risk-management strategy with Songbird Life Science. We test people and surfaces (and soon will test air and water) to effectively confirm if the virus is present. A positive test result signals a pre-planned response to be activated. A negative test confirms that existing measures and protocols are working. And should a positive result occur, Songbird experts will then review the existing risk-management plans and facilities to assess whether additional modifications are needed.

Reliable and accurate with PCR

When testing is required, Songbird only applies DNA/RNA-identification technologies able to accurately identify the two genetic markers of the COVID-19 virus strain. PCR or LAMP technology, which is specific and sensitive enough to identify the distinct genetic markers of the virus, is applied. A testing regime is only deployed according to a space or community’s specific requirements. Most often, the preferred option is rapid, onsite testing, where results—and any required actions—can happen quickly.

Multiple testing options

Test regularly for pathogens. Surface and human now; air and water testing in development.

2 delivery methods

Rapid onsite self-screening; managed off-site testing.

Testing insights

Scientific analysis informs risk-management systems, building modifications, and usage patterns.

bCUBE in hand

Hyris bCUBE: Approved by Health Canada

The Hyris bCUBE is a portable DNA-testing laboratory in a box, offering Point-of-Care (POC) testing wherever people are—any time, anywhere. Approved by Health Canada, the bCUBE can be controlled by any device with an internet connection, including a smartphone. The scientifically validated bCUBE analyzes collected samples through a cloud-based platform that delivers accurate results in 90 minutes.

The bCUBE deploys PCR (Polymerase Chain Reaction) technology that is considered the “gold standard” of testing according to the CDC and WHO’s effective testing guidelines. In clinical trials, the device demonstrated a 95%+ accuracy rate. Similar trials are currently underway with the FDA.

The bCUBE is a small, portable genomic biotechnology that is ideal for onsite, immediate test results. We have validated the bCUBE after using it for several years in the food and natural products industry to identify pathogens, microbes, animal and botanical species ingredients.

— Dr. Steven Newmaster, University of Guelph Genomics Professor

songbird risk calculator

Beyond Testing

An effective testing strategy is key to managing the risk of pathogens—but it must go beyond a test kit and a swab. Accurate testing is dependent on training onsite staff to deploy tests correctly. Test results tell a story. Pathogen and building scientists will interpret that data to determine what adjustments or facility modifications are needed.

What role might ventilation or air quality be playing in transmission? Should existing hygiene or personal protective measures be upgraded—or can they safely be reduced? Learn more about the complete suite of science-based services that truly reduce pathogen risk.

Make your shared space safer today